Dimethyltryptamin/harmine

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameDimethyltryptamin/harmine

Drug Alias NameDMT/harmineRE01RE-01

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitorsDYRK kinase inhibitors +[6]

TargetsSerotonin 2a (5-HT2a) receptorDual-specificity tyrosine-phosphorylation regulated kinase 1ADYRK kinase +[5]

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsYes Dimethyltryptamine Harmine hydrochloride

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesReconnect Labs

China Registration ClassN/A

Develop Information

Active CompaniesReconnect Labs

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A